My fasting blood glucose is 248 mg/dL while taking insulin glargine (Lantus) 42 units nightly; how many units should I increase the Lantus dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lantus Dose Adjustment for Overnight Hyperglycemia

Increase your Lantus dose by 4 units (from 42 to 46 units) tonight, and continue increasing by 4 units every 3 days until your fasting blood glucose consistently reaches 80–130 mg/dL. 1

Immediate Dose Adjustment Protocol

Your fasting blood glucose of 248 mg/dL falls into the category requiring aggressive titration:

  • When fasting glucose is ≥180 mg/dL, increase basal insulin by 4 units every 3 days until reaching the target range of 80–130 mg/dL 1
  • At your current dose of 42 units, this represents approximately a 10% increase, which is within the recommended 10–15% adjustment range 1
  • Continue this 4-unit increment every 3 days as long as your fasting glucose remains ≥180 mg/dL 1

Target and Monitoring

  • Your target fasting glucose is 80–130 mg/dL 1
  • Check your fasting blood glucose every morning during this titration phase to guide dose adjustments 1
  • If you experience any blood glucose <70 mg/dL, immediately reduce your Lantus dose by 10–20% (approximately 4–8 units) and contact your provider 1

Critical Threshold Awareness

  • When your Lantus dose approaches 0.5 units/kg/day (which varies by body weight), you may need to add mealtime insulin rather than continuing to increase basal insulin alone 1
  • Signs you may need mealtime insulin include: basal dose >0.5 units/kg/day, large overnight glucose drop (≥50 mg/dL from bedtime to morning), episodes of hypoglycemia, or high glucose variability throughout the day 1
  • At these thresholds, continuing to escalate Lantus beyond 0.5–1.0 units/kg/day without addressing post-meal hyperglycemia leads to increased hypoglycemia risk without improved control 1

Foundation Therapy Considerations

  • Continue metformin at maximum tolerated dose (up to 2,000–2,550 mg/day) unless contraindicated, as this combination reduces total insulin requirements by 20–30% and provides superior glycemic control 1
  • If you're not currently on metformin, discuss starting it with your provider 1

Safety Precautions

  • Treat any glucose <70 mg/dL immediately with 15 grams of fast-acting carbohydrate, recheck in 15 minutes, and repeat if needed 1
  • Always carry a source of fast-acting carbohydrates 1
  • Never skip your Lantus dose entirely, even if you're not eating, as basal insulin suppresses liver glucose production independent of food intake 1

When to Contact Your Provider

  • If fasting glucose remains >180 mg/dL after 2–3 weeks of titration 1
  • If you experience any glucose <70 mg/dL 1
  • If your Lantus dose exceeds 0.5 units/kg/day (calculate based on your weight in kg) without achieving fasting glucose targets 1
  • If you develop symptoms such as nausea, vomiting, or abdominal pain with high blood sugars, as these may indicate ketones 1

Expected Outcomes

  • With proper titration using this algorithm, approximately 68% of patients achieve mean glucose <140 mg/dL 1
  • The 4-unit increment every 3 days for glucose ≥180 mg/dL is specifically designed to achieve target fasting glucose efficiently while minimizing hypoglycemia risk 1, 2

Related Questions

What is the typical starting dose of Lantus (insulin glargine) for patients requiring insulin therapy?
What is the recommended starting dose of Lantus (insulin glargine) for patients with type 1 or type 2 diabetes?
What is the best approach for controlling hyperglycemia in a patient with type 2 diabetes who missed a dose of Lantus (insulin glargine) and is NPO for a right heart catheterization?
What adjustments should be made to the Lantus (insulin glargine) dose, carb ratio, and correction scale for a 25-year-old male with type 1 diabetes, body mass index (BMI) 21, and elevated fasting blood glucose level of hyperglycemia, currently on 36 units of Lantus daily?
What is the best treatment plan for a patient with uncontrolled type 2 diabetes mellitus (T2DM) with hyperglycemia, who has a history of insulin use, and is currently being treated for acute urinary tract infection (UTI), diabetic polyneuropathy, and chronic gastritis, considering the use of Lantus (insulin glargine) and Farxiga (dapagliflozin)?
What are the recommended indications, dosing regimen (loading and maintenance), renal dose adjustments, therapy duration, monitoring parameters, and alternative agents for teicoplanin in adult patients with serious Gram‑positive infections?
What is the most appropriate secondary-prevention strategy for an elderly obese woman with symptomatic heart failure, diabetes mellitus, and chronic kidney disease?
What is the appropriate teicoplanin dosing regimen (loading, maintenance, renal adjustment, duration, and therapeutic drug monitoring) for an adult with a serious Gram‑positive infection such as endocarditis, septic arthritis, or complicated bacteremia?
In a 52‑year‑old obese woman with known diabetes, a waist circumference of 125 cm, hip circumference of 100 cm, and LDL cholesterol of 4.3 mmol/L, which marker is the most appropriate indicator: LDL cholesterol, body mass index, waist‑hip ratio, or waist circumference?
What are the absolute and relative contraindications for performing a laryngectomy?
What is the mean arterial pressure for a blood pressure of 99 mmHg systolic and 52 mmHg diastolic?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.